Clinical dermatoscopy and pathological slide assessment are essential in the diagnosis and
management of patients with cutaneous melanoma. For those presenting with stage IIC …

Biomarkers help to inform the clinical management of patients with melanoma. For patients
with clinically localised primary melanoma, biomarkers can help to predict post-surgical …

Determining early-stage prognostic markers and stratifying patients for effective treatment
are two key challenges for improving outcomes for melanoma patients. Previous studies …

Much evidence has accumulated to show that inflammation and nutritional status are
associated with the prognosis of patients with various cancers. The present study was …

Introduction The presence of tumor-infiltrating lymphocytes (TILs) in melanoma has been
linked to survival. Their predictive capability for immune checkpoint inhibition (ICI) response …

Background Immune checkpoint inhibitor (ICI) has been widely used in the treatment of
advanced cancers, but predicting their efficacy remains challenging. Traditional biomarkers …

With an increasing incidence of malignant melanoma, new prognostic biomarkers for clinical
decision making have become more important. In this study, we evaluated the role of ecto …

Melanoma is an immunogenic tumor that exhibits various cell types in its microenvironment,
including fibroblasts, endothelial cells, and immune cells. The interaction of tumor cells with …

Purpose Numerous studies underscore the relevance of tumor-infiltrating-lymphocytes (TILs)
as important prognostic factors for melanoma. This meta-analysis aims to provide a …

Simple Summary This study explores the therapeutic effect of the combination of BRAF and
MEK inhibitors (BRAFi+ MEKi) on NRAS-mutated melanomas in vitro, in preclinical in vivo …